Preclinical results indicate new approach could be a way to deliver treatment directly to tumors at higher doses, while reducing side effects in healthy tissue.

Researchers developed a chimeric cancer drug that links an Aurora kinase A inhibitor to a tumor-targeting molecule. In ...

Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more ...